Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

110.400
+14.60015.24%
Volume:10.61M
Turnover:1.13B
Market Cap:62.22B
PE:75.04
High:111.500
Open:100.500
Low:98.300
Close:95.800
52wk High:126.600
52wk Low:21.050
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:2.06
T/O Rate:5.09%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.471
ROE:25.37%
ROA:1.37%
PB:15.12
PE(LYR):75.04
PS:16.78

Loading ...

RemeGen (09995.HK/688331) Announces No Change in Share Capital for October 2025

Bulletin Express
·
Nov 04, 2025

JPMorgan Raises REMEGEN (09995) Target Price to HK$77, Upgrades to Neutral

Stock News
·
Nov 04, 2025

RemeGen’s Reduced Losses and Telitacicept Results Could Be a Game Changer for RemeGen (SEHK:9995)

Simply Wall St.
·
Nov 04, 2025

Bank of Communications International Raises REMEGEN (09995) Target Price to HK$112, Maintains "Buy" Rating

Stock News
·
Nov 04, 2025

RemeGen (9995) Announces RMB400 Million Principal-Guaranteed Wealth Management Product Purchase

Bulletin Express
·
Nov 03, 2025

REMEGEN (09995) Purchases RMB 400 Million in Wealth Management Products

Stock News
·
Nov 03, 2025

RemeGen (SEHK:9995) Valuation in Focus Following Breakthrough Clinical Results and Improved Financials

Simply Wall St.
·
Nov 02, 2025

RemeGen (SEHK:9995) Losses Widen 23.9% Annually, Profitability Forecasts Test Investor Optimism

Simply Wall St.
·
Nov 01, 2025

RemeGen Posts Q3 Loss Despite Higher Revenue; Shares Rise 7%

MT Newswires Live
·
Oct 31, 2025

Stock Track | REMEGEN Soars 8.40% as Hong Kong Biotech Stocks Rally

Stock Track
·
Oct 31, 2025

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31, 2025

RemeGen Co., Ltd.* (9995) Announces 2025 Third Quarter Results

Bulletin Express
·
Oct 30, 2025

RemeGen (9995) Announces Renewals of Continuing and One-off Connected Transactions

Bulletin Express
·
Oct 30, 2025

Visual Guide to REMEGEN's Q3 2025 Earnings Report

Deep News
·
Oct 30, 2025

REMEGEN (09995) Reports Q3 Results: Net Loss Narrows 48.6% YoY to RMB 551 Million

Stock News
·
Oct 30, 2025

HK Stock Connect Shareholding Changes as of October 30

Stock News
·
Oct 30, 2025

Caitong Securities: Phosphoramidite Monomer Demand to Boom, Companies in MNC Pharma Supply Chains Set to Benefit

Stock News
·
Oct 29, 2025

HK Stock Connect Shareholding Changes | Oct 28

Stock News
·
Oct 28, 2025

RemeGen (SEHK:9995) Is Down 8.4% After Breakthrough Phase III Results Gain Global Recognition – Has the Bull Case Changed?

Simply Wall St.
·
Oct 26, 2025

Asian Growth Companies With High Insider Ownership In October 2025

Simply Wall St.
·
Oct 22, 2025